Crinetics Pharmaceuticals CRNX Cash Cash Equivalents And Short Term Investments
Cash Cash Equivalents And Short Term Investments at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsAndShortTermInvestments.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's cash cash equivalents and short term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's cash cash equivalents and short term investments?
- Crinetics Pharmaceuticals (CRNX) reported cash cash equivalents and short term investments of $1.3B in Q1 2026.